Unione Europea - italiano - EMA (European Medicines Agency)

ucb pharma s.a. - lacosamide - epilessia, parziale - antiepilettici, - lacosamide ucb è indicato come monoterapia e in terapia aggiuntiva nel trattamento di parziale-inizio convulsioni con o senza secondaria generalizzazione in adulti, adolescenti e bambini a partire dai 4 anni di età con epilessia.

Unione Europea - italiano - EMA (European Medicines Agency)

extrovis eu ltd. - lacosamide - epilessia - antiepilettici, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - loperamidi hydrochloridum - loperamid streuli 2 mg - loperamidi hydrochloridum 2 mg, lactosum monohydricum 225.5 mg, talco, kapselhülle: gelatina, pro capsula. - antidiarrhoikum - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - lacosamide - epilessia - antiepilettici, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

teva b.v. - lacosamide - lacosamide

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lacosamidum - compresse rivestite con film - lacosamidum 50 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, crospovidonum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, e 132, e 171, e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - antiepileptikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lacosamidum - compresse rivestite con film - lacosamidum 100 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, crospovidonum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, e 171, e 172 (flavum) pro compresso obducto. - antiepileptikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lacosamidum - compresse rivestite con film - lacosamidum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, crospovidonum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - antiepileptikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lacosamidum - compresse rivestite con film - lacosamidum 200 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, crospovidonum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, e 132, e 171 pro compresso obducto. - antiepileptikum - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

g.l. pharma gmbh - lacosamide - lacosamide